Biomarkers to predict decreased bone mineral density in patients with chronic respiratory failure Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Bone turnover markers, bone mineral density and body composition in Tunisian patients with chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021
Bone mineral density in patients with COPD depending on pulmonary function parameters Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Loss of bone mineral density in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Primary care management of COPD Year: 2007
Undertreatment of loss of bone mineral density in patients with COPD who were referred for pulmonary rehabilitation Source: Eur Respir J 2006; 28: Suppl. 50, 71s Year: 2006
Lung transplantation after bone marrow transplantationin paediatric patients Source: Eur Respir J 2006; 28: Suppl. 50, 725s Year: 2006
Bone mineral density in relation to underweight and body composition in candidates for lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 60s Year: 2001
Pulmonary hypertension after bone marrow transplantation in children Source: Eur Respir J, 54 (5) 1900612; 10.1183/13993003.00612-2019 Year: 2019
Bone mineral density is related to exercise capacity in COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Bone mineral density and calciun metabolism in sarcoidosis at clinical onset Source: Eur Respir J 2004; 24: Suppl. 48, 714s Year: 2004
Pulmonary involvement in haematological disorders and bone marrow transplant recipients Source: Eur Respir Monogr 2019; 86: 333-358 Year: 2019
Evaluation of bone mineral density in lung transplantation candidates with end stage lung disease Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015
Bone mineral density changes in male patients with chronic obstructive pulmonary disease: clinical and biochemical variables in correlation with glucocorticoids use Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009
Bone marrow characteristics in patients with COPD and eosinophilia Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
Bone mineral density (BMD) measuring in patients suffering from pulmonary disease under glucocorticoid treatment - fashioned trend or necessity? Source: Eur Respir J 2005; 26: Suppl. 49, 526s Year: 2005
Pulmonary dysfunction after bone marrow transplantation (BMT) for thalassemia major: long-term results Source: Eur Respir J 2004; 24: Suppl. 48, 157s Year: 2004
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler(R) Source: Eur Respir J 2002; 19: 1058-1063 Year: 2002
Telespirometry for home monitoring of pulmonary function in patients after allogeneic bone marrow transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 242s Year: 2003
Changes in bone mineral density after lung volume reduction surgery for severe emphysema Source: Eur Respir J 2002; 20: Suppl. 38, 607s Year: 2002
Current status of research on osteoporosis in COPD: a systematic review Source: Eur Respir J 2009; 34: 209-218 Year: 2009